LOXL3 and liver neoplasm: As LOX and LOXL3 were both found to be overexpressed in LC and associated with worse OS, further exploration of potential interacting drugs was conducted by using Coremine Medical, which identified 30 drugs that were associated with both LOX and LOXL3 in liver neoplasms (Figure 6).